Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 41 - 60 results of 59,357 for search '(( 2 d decrease ) OR ( 100 ((nn decrease) OR (((teer decrease) OR (a decrease)))) ))', query time: 1.10s Refine Results
  1. 41
    Homocysteine decreases G9a expression both <i>in vitro</i> and <i>in vivo</i>.

    Homocysteine decreases G9a expression both <i>in vitro</i> and <i>in vivo</i>. by Wenjing Lei (772749)

    Published 2015
    Save to List
    Saved in:
  2. 42
    Hcy decreased the binding of G9a to the <i>COL1A1</i> promoter.

    Hcy decreased the binding of G9a to the <i>COL1A1</i> promoter. by Wenjing Lei (772749)

    Published 2015
    Save to List
    Saved in:
  3. 43
    NDRG2 is decreased during LX-2 activation.

    NDRG2 is decreased during LX-2 activation. by Jiandong Yang (196004)

    Published 2011
    Save to List
    Saved in:
  4. 44
    Resveratrol decreases cell proliferation in a time and dose dependent manner.

    Resveratrol decreases cell proliferation in a time and dose dependent manner. by Mehtap Kilic Eren (591048)

    Published 2015
    Save to List
    Saved in:
  5. 45
    Pendrin gene ablation increases force/cross-sectional area and decreases thickness of the aorta.

    Pendrin gene ablation increases force/cross-sectional area and decreases thickness of the aorta. by Roy L. Sutliff (485240)

    Published 2014
    Save to List
    Saved in:
  6. 46
    Dexamethasone decreases CRTC1 and CRTC2 nuclear localization.

    Dexamethasone decreases CRTC1 and CRTC2 nuclear localization. by Jill A. Rahnert (2872766)

    Published 2016
    “…<p>Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased (A) total CRTC1 (p = 0.004 and CRTC2 protein (p = 0.0007). n = 9/treatment from 3 experiments. …”
    Save to List
    Saved in:
  7. 47
    Mice carrying 100P mutations show layer-specific decreases in proportions of PV+ cells.

    Mice carrying 100P mutations show layer-specific decreases in proportions of PV+ cells. by Malgorzata Borkowska (3166719)

    Published 2016
    “…<p>(<b>A-D</b>) Decreases occurred in layer IV in fSSp, SSp, vAud and Vis, in layer V in SSp, vAud and Vis and in layer II/III in SSp. …”
    Save to List
    Saved in:
  8. 48
    DNA damage induces a pan-nuclear decrease in GFP-lamin A mobility.

    DNA damage induces a pan-nuclear decrease in GFP-lamin A mobility. by Robert Mahen (409641)

    Published 2013
    Save to List
    Saved in:
  9. 49
    Dark-rearing during the visual sensitive period decreases MeCP2 expression within the dLGN.

    Dark-rearing during the visual sensitive period decreases MeCP2 expression within the dLGN. by Yuki Yagasaki (402238)

    Published 2018
    Save to List
    Saved in:
  10. 50
    F-actin decreases after M64HCl treatment in Caco-2 cells.

    F-actin decreases after M64HCl treatment in Caco-2 cells. by Sema Oncel (10152053)

    Published 2024
    Save to List
    Saved in:
  11. 51
    Dexamethasone decreases PGC-1α protein expression and transcription.

    Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

    Published 2016
    “…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”
    Save to List
    Saved in:
  12. 52
    D452A, E464A, E470A, and E475A mutations decreased the calcium sensitivity.

    D452A, E464A, E470A, and E475A mutations decreased the calcium sensitivity. by Qinghuan Xiao (573411)

    Published 2014
    Save to List
    Saved in:
  13. 53
    Treatment with a highly reducing agent decreases ubiquitination of D<sub>4.2</sub>R WT and D<sub>4.2 4KR</sub>R mutant.

    Treatment with a highly reducing agent decreases ubiquitination of D<sub>4.2</sub>R WT and D<sub>4.2 4KR</sub>R mutant. by Kamila Skieterska (841014)

    Published 2016
    Save to List
    Saved in:
  14. 54
    Confocal images presenting the phenotypes of S100A6-immunopositive cells in the SVZ.

    Confocal images presenting the phenotypes of S100A6-immunopositive cells in the SVZ. by Katarzyna Bartkowska (453261)

    Published 2017
    Subjects:
    Save to List
    Saved in:
  15. 55
    Confocal images presenting the phenotypes of S100A6-immunopositive cells in the ARH.

    Confocal images presenting the phenotypes of S100A6-immunopositive cells in the ARH. by Katarzyna Bartkowska (453261)

    Published 2017
    Subjects:
    Save to List
    Saved in:
  16. 56
    GluN2A(D731N) reduces the agonist potency.

    GluN2A(D731N) reduces the agonist potency. by Kai Gao (120150)

    Published 2017
    Subjects:
    Save to List
    Saved in:
  17. 57
    Removal of the A-B linker did not decrease PIP<sub>2</sub> affinity. <i>A.-</i>

    Removal of the A-B linker did not decrease PIP<sub>2</sub> affinity. <i>A.-</i> by Paloma Aivar (124885)

    Published 2012
    Save to List
    Saved in:
  18. 58
    Treatment with FTY720 induces a decrease in inactive (phosphorylated) SAMHD1.

    Treatment with FTY720 induces a decrease in inactive (phosphorylated) SAMHD1. by Rachel S. Resop (9238645)

    Published 2020
    Save to List
    Saved in:
  19. 59
    Rho activation resulted in a growth cone collapse, but not decreased neurite lengths.

    Rho activation resulted in a growth cone collapse, but not decreased neurite lengths. by Frank Roloff (695802)

    Published 2015
    Save to List
    Saved in:
  20. 60
    Tetrandrine decreases Mtb antigen presentation.

    Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

    Published 2025
    Save to List
    Saved in:

Search Tools: